Co-Diagnostics and ReadyGo assess blood-based PCR testing for decentralized Ebola detection

Sep 16, 2026 12:45 (39d ago)

Verifying

Co-Diagnostics and ReadyGo are evaluating combined technologies for blood-based Ebola testing.
The outbreak has recorded 6,757 confirmed cases and 3,267 deaths as of Sept. 7, 2026.
Co-Diagnostics received ReadyGo devices, while platform compatibility and commercial availability remain unconfirmed.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.